TRIB2 and prostate carcinoma: Increased mRNA expression of TRIB2 (denoted as GS3955) was observed previously by Bisoffi et al. (17), in the androgen-resistant (C4-2 and PC3) prostate cancer cells compared to androgen-sensitive (LNCaP) cells.